The news of Wedbush maintaining a Neutral rating on DocuSign and raising the price target from $60 to $67 indicates that the analyst sees potential growth in the stock but remains cautious. This may not have a significant short-term impact on the stock price, as the rating remains unchanged. However, the increased price target may attract some investors, but overall, the impact is expected to be neutral.